event tracking

Epigenetics

129 results.

December 16, 2024 VAI Research: A year in review

The past year at Van Andel Institute can be summed up in two words: “growth” and “impact.”

We’ve expanded our research capacity by adding new…

December 9, 2024 Van Andel Institute, Johns Hopkins University scientists to receive prestigious Harvey Prize

GRAND RAPIDS, Mich. (Dec. 9, 2024) — A trio of esteemed scientists from Van Andel Institute and Johns Hopkins University will receive the Harvey Prize for their…

November 19, 2024 Van Andel Institute scientists named to prestigious Highly Cited Researchers list

GRAND RAPIDS, Mich. (Nov. 19, 2024) — Van Andel Institute scientists Russell Jones, Ph.D., and Peter W. Laird, Ph.D., are included in this year’s Clarivate Highly Cited Researchers…

October 21, 2024 Van Andel Institute Chief Scientific Officer Dr. Peter A. Jones elected to National Academy of Medicine

GRAND RAPIDS, Mich. (Oct. 21, 2024) — Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has been elected to the

October 10, 2024 Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy

MEMPHIS, Tenn. (Oct. 10, 2024) — Immunotherapy, using a patient’s own immune system to treat disease, has shown promise in some patients with cancer but…

August 29, 2024 New anti-cancer ‘degrader’ targets protein essential to infant leukemia

GRAND RAPIDS, Mich. (Aug. 29, 2024) — Scientists at Van Andel Institute and Icahn School of Medicine at Mount Sinai have developed…

June 27, 2024 Epigenetics expert Dr. Derek Janssens joins Van Andel Institute

GRAND RAPIDS, Mich. (June 27, 2024) — Van Andel Institute has recruited epigenetics expert Derek Janssens, Ph.D., whose leading-edge research explores the nuanced factors that…

June 26, 2024 New research aims to improve cancer immunotherapy

To say that immunotherapies have been a game-changer for cancer feels like an incredible understatement.  

These powerful treatments, which work by bolstering the immune…